Academician Cao Xuetao was born in 1964, graduated from Shanghai Second Military Medical University, received his bachelor's degree in 1986, received his doctor's degree in 1990, and was promoted to professor in 1992. In 2004, he served as vice president of the Second Military Medical University, and was elected as an academician of China Academy of Engineering in 2005 (4/2005). 20 1 1 has been the president of China academy of medical sciences, and 20 15 concurrently served as the president of Peking union medical college (formerly Peking union medical college). Now he is a foreign academician of German Academy of Sciences, British Academy of Medical Sciences and French Academy of Medical Sciences.
Cao Xuetao is an immunologist with international academic influence, who has long been engaged in basic research on anti-infective natural immunity and inflammation, as well as applied research on the transformation of tumor immunotherapy. He has published more than 240 papers by correspondence author SCI, and published many research papers in Cell, Nature, Science and Nature Immunology. In the last five years. The dendritic cell vaccine developed for clinical trial treatment of advanced tumor patients has completed the second phase clinical trial and obtained the approval of CFDA for the third phase clinical trial.
It is reported that the National Academy of Medical Sciences (NAM) is a national academic institution in the United States alongside the National Academy of Sciences (NAS) and the National Academy of Engineering (NAE), and currently has more than 2,000 academicians including dozens of Nobel Prize winners.